<DOC>
	<DOCNO>NCT01980485</DOCNO>
	<brief_summary>Narrative : Tobacco smoking remain single big cause premature death United States lead cause cancer death cancer . There therefore urgent need find effective practical way help smoker quit stay quit . This randomized trial aim evaluate two promise method help smoker quit stay quit . Design : This randomize control smoke cessation trial two stage . In Stage 1 , 225 smoker recruit assessment randomly allocate receive feedback `` Lung Age '' estimate Forced Expiratory volume air lungs one second ( FEV1 ) , exhale carbon-monoxide ( CO ) ( Intervention group 1 ) measure feed back manner design enhance motivation quit ( Control group 1 ) . All participant provide group counsel ( 6 weekly session , target Quit Date day second group meeting ) , transdermal nicotine patch . Main outcome measure : Stage 1 , Past week tobacco abstinence biochemically validate exhaled CO &lt; 10 ppm visit 7 ( 4 week Target Quit Date ) . In Stage 2 ( start visit 7 ) , participant attend visit 7 ( 28 day Target Quit Date ) , randomly allocate receive either Forever Free relapse prevention material ( Intervention 2 ) http : //www.smokefree.gov/pdf.html Surgeon General 's Guide `` How Tobacco Smoke Causes Disease '' ( Control 2 ) http : //www.cdc.gov/tobacco/data_statistics/sgr/2010/consumer_booklet/index.htm . All randomized participant receive follow-up phone call week later remind read use material give , attend follow visit ( 8 ) , 6 month initial Target Quit Date . Main outcome measure : Stage 2 . Among smoked previous week visit 7 , sustain tobacco abstinence ( include tobacco use prior 7 day ) , validate exhaled CO &lt; 10 ppm 6 month visit ( 8 ) AND smoke 7 consecutive day prior 5 month ( definition relapse study ) . Hypothesis : Smokers provide lung age feedback assessment high quit rate 28 day target quit date .</brief_summary>
	<brief_title>The Get Quit - Stay Quit Study</brief_title>
	<detailed_description />
	<mesh_term>Carbon Monoxide</mesh_term>
	<criteria>1 . Participants must report smoke least 5 cigarette per day previous 6 month AND sometimes smoke least 10 cigarette one day . 2 . Participants must want quit smoke ready make quit attempt within next 30 day . 3 . Participants must plan remain intervention catchment area least 8 month . 4 . Age &gt; 18 year . Nicotine patch currently approve FDA age 18 . 5 . Participants must willing attend provide data 8 study visit , include assessment visit blood sample drawn , 6 group treatment session , respond followup telephone call , 6month followup visit . 6 . Participants must able read write English . 7 . Nicotine know harmful develop human fetus recommend therapeutic dose . For reason woman childbearing potential must agree use adequate contraception ( hormonal barrier method birth control ; abstinence ) prior study entry standard duration transdermal nicotine therapy ( 10 week ) . Should woman become pregnant suspect pregnant partner participate study , patient inform treat clinician immediately . 8 . Ability understand willingness sign write informed consent document 1 . A history severe allergic reaction use nicotine patch . 2 . Currently use drug/medicine aid smoking cessation ( e.g . Zyban , Chantix , nicotine replacement ) . 3 . Currently pregnant , try get pregnant , nursing , nicotine know harmful develop human fetus recommend therapeutic dose . 4 . Had heart attack , stroke , continue arrhythmias angina ( chest pain ) abnormal electrocardiogram within past 4 week . 5 . Uncontrolled serious mental illness substance abuse . 6 . Uses noncigarette tobacco product plan quit tobacco .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>smoker</keyword>
</DOC>